Mark P Labrecque
8PUBLICATIONS
93CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.Xing Wei, Cristina Blaj, M Ali Al-Radhawi
|Oct 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.Ailin Zhang, Nathan A Lau, Alicia Wong
|Oct 05, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.Mark P Labrecque, Lisha G Brown, Ilsa M Coleman
|Jul 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.Mark P Labrecque, Lisha G Brown, Ilsa M Coleman
|Jun 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.Dae-Hwan Kim, Duanchen Sun, William K Storck
Pageof 2
Frequent Collaborators
6 joint publications
Eva Corey
3 joint publications
John K Lee
3 joint publications
Joshi J Alumkal
2 joint publications
Navonil De Sarkar
2 joint publications
Mallika Singh
2 joint publications
Yongxian Zhuang
2 joint publications
Jingjing Jiang
2 joint publications
Jacqueline A M Smith
2 joint publications
Colm Morrissey
1 joint publications
Dae-Hwan Kim